KCPG
CELG

Kavar Capital Partners Group’s Celgene Corp CELG Stock Holding History

Kavar Capital Partners Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17
Closed -$1K – 557
2015
Q3 		$1K Sell
17
-13
-43% -$1.61K ﹤0.01% 476
2015
Q2 		$3K Buy
+30
New +$3.43K ﹤0.01% 373
2014
Q2 		– Sell
-40
Closed -$2K – 566
2014
Q1 		$2K Sell
40
-200
-83% -$15.8K ﹤0.01% 413
2013
Q4 		$20K Buy
+240
New +$19K 0.02% 247

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Kavar Capital Partners Group's CELG Position: Q4 2015 in Review

Kavar Capital Partners Group sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 17 shares — an estimated $1K sold.

Kavar Capital Partners Group first reported a position in CELG in Q4 2013 and held it in 4 quarters. The position peaked at $20K in Q4 2013. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Kavar Capital Partners Group reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • Kavar Capital Partners Group sold 17 Celgene Corp shares in Q4 2015, an estimated $1K.
  • Kavar Capital Partners Group first reported a position in Celgene Corp in Q4 2013 and held it in 4 quarters.
  • Kavar Capital Partners Group's Celgene Corp position peaked at $20K in Q4 2013.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Kavar Capital Partners Group's 13F filing for Q4 2015, filed 1 May 2019.